that a bright-line test would be applied requiring at least one civil judgment in favor of a plaintiff before a
defendant would be required to disclose allegations of a link between a drug and an adverse effect and that the
defendants were entitled to dismissal of the case because no showing of a civil judgment had been introduced.
that no statistical link between the use of the drug and adverse effects was required but that the defendants
were entitled to dismissal of the case because the plaintiffs did not personally suffer adverse health effects
from the drug.
that the defendants were entitled to dismissal of the case because the plaintiffs could not prove a statistical link
between use of the drug and adverse effects.
that the “total mix of information” test applied in regard to the issue of materiality, that statistical proof was
unnecessary, and that sufficient evidence existed for the plaintiffs to proceed to trial.
38. In Stoneridge Investment Partners, LLC v. Scientific-Atlanta, Inc. referenced in the text, the U.S Supreme Court
analyzed the question of whether customer / supplier companies that agreed to arrangements allowing an issuer to
mislead its auditor are liable in a private action under section 10(b) of the 1934 Act. The Court ruled:
that based on “scheme liability,” the customer / supplier companies could be held liable although no public
statement was made.
that based on “transaction causation” the plaintiffs could establish reliance and that the plaintiffs were,
therefore, entitled to proceed.
that plaintiff investors had no private right of action because they did not rely upon the statements or
representations at issue.
that the plaintiff investors had no private right of action because the defendants were not aiders and abettors
and, instead, acted primarily on their own behalf outside the realm of securities regulation.
United States – BUSBROG: – Analytic
39. Which of the following is true regarding who can sue under Rule 10b–5?
Only those who purchased the securities at issue may sue.
Only those who sold the securities at issue may sue.
Only those who have actually purchased or sold the securities at issue may sue.
Anyone who either actually purchased or sold the securities at issue, and also anyone who can prove that he or
she would have purchased or sold the securities at issue had they known the true facts may sue.
United States – BUSBROG: – Analytic
United States – BUSBROG: – Analytic
DISC: – AICPA: BB-Legal
22-5 Materiality
Blooms: Analysis